MEDSHAW LIMITEDActive
Key figures
Like most small UK companies, MEDSHAW LIMITED does not publish a profit and loss account in its latest accounts. The figures below come from the balance sheet.
Ratios
2024/25Balance sheet structure
Filed accounts2019/20–2024/25
| 2020/21 | 2021/22 | 2022/23 | 2023/24 | 2024/25 | |
|---|---|---|---|---|---|
| Cash at bank and in hand | 28,890 | 73,029 | 151,530 | 159,533 | 216,514 |
| Total assets | 55,859 | 98,528 | 173,781 | 179,030 | 244,441 |
| Total liabilities | 4,858 | 10,730 | 21,197 | 13,005 | 26,031 |
| Net assets / total equity | 51,001 | 87,798 | 152,584 | 166,025 | 218,410 |
| Average number of employees | 1 | 1 | 1 | 1 | 1 |
| Average pay (per year) | — | — | — | 43,797 | — |
A dash (—) means no accounts were filed for that year or the item is not in the accounts; 0 is a zero stated in the accounts. Small companies usually file only a balance sheet, so the profit and loss account is often missing.
Principal activity
Accounts 2025medical services
As described in the company's latest filed accounts.
Summary: MEDSHAW LIMITED
Company
MEDSHAW LIMITED is a private limited company registered with Companies House under company number 08031369. It was incorporated on 16 Apr 2012. Its status is active. The registered office is in Swansea (SA4). Its nature of business (SIC 2007) is other letting and operating of own or leased real estate (68209), post-graduate level higher education (85422), specialists medical practice activities (86220).
Accounts
The latest accounts in the database are for 2024/25 (period ending 31 Mar 2025); the company files small company accounts (filleted). Net assets were £218,410, up 31.6% on the previous year. Cash at bank and in hand was £216,514. Total assets were £244,441 and total liabilities £26,031. The company had an average of 1 employee. Figures are available for 6 financial years (2019/20–2024/25).
Control and charges
One person with significant control is registered.
Filing deadlines
The next accounts are due by 31 Dec 2026. The next confirmation statement is due by 30 Apr 2027.